Our latest news
COSMO’s latest news.
【COSMO News】 The Acceleration of Digital Health in Japan Amid COVID-19
-The 1st COSMO Innovation Seminar- COVID-19 is prompting an acceleration in digital transformation across all sectors. In the healthcare sector, there is growing anticipation for online medical care, app-based treatments, and “digital health”, or health management using digital devices. Regulation prohibiting physicians from providing online medical examinations to first-time patients was lifted in April this
What is the pathway to patient-centric ethical drug development?
Pathway to patient-centric drug development Shift from patient engagement to public engagement Healthcare in Japan is transitioning from care that patients passively receive, to one that they independently choose. This trend is becoming increasingly important, not only in terms of patients’ conducting their own research and openly discussing information with healthcare professionals, but also within
Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio
Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio HekaBio K.K. (hereafter: HekaBio) and Cosmo Public Relations Corporation (hereafter: Cosmo) have announced that Cosmo has made an investment in HekaBio and that the companies have entered into a strategic partnership to increase awareness of and accessibility to emerging innovations in the bioscience